Jülg, BBarouch, DH2016-10-112015Jülg, B., and DH Barouch. 2015. “Novel immunological strategies for HIV-1 eradication.” Journal of Virus Eradication 1 (4): 232-236.2055-6640http://nrs.harvard.edu/urn-3:HUL.InstRepos:29002420Abstract Despite the significant advances in antiretroviral therapy (ART), HIV-1 is able to persist in cellular reservoirs. Preclinical studies suggest that the latent reservoir is established within days of virus exposure, even before virus can be detected in peripheral blood. Latently infected cells remain undetectable by the immune system and can persist for years without losing their ability to produce infectious virus when ART is discontinued. Novel concepts for viral eradication strategies combine pharmacological induction of latently infected cells to produce virus together with immune-enhancing interventions to enable the host to clear these cells. In this review, we describe the early establishment of HIV-1 latency and discuss current strategies to disrupt latency and potentially enable clearance of these persistently infected cells.en-USHIV-1 reservoirHIV-1 latencyHIV-1 curelatency disruptiontherapeutic vaccinesJournal Article2016-10-11